safety

September 10, 2018September 10, 2018

Patient Death in Phase 2b Prostate Cancer Trial Unrelated to Topsalysin, Sophiris Says

News

Topsalysin (PRX302), an investigative agent for localized prostate cancer, is unlikely to have caused the death of a patient in a Phase 2b trial testing the medicine, Sophiris Bio announced. A review of clinical ... Read more

February 5, 2018

Panacea Completes Patient Enrollment in Phase 1 Trial of Prostate Cancer Vaccine

News

Panacea Pharmaceuticals has completed patient enrollment in a Phase 1 clinical trial testing its PAN-301-1 vaccine as a treatment for prostate cancer that has failed to respond to other therapies. The multi-center trial (NCT03120832) ... Read more

December 7, 2017

Safety Concerns Make Bayer Unblind Prostate Cancer Trial of Xofigo Combination

News

An Independent Data Monitoring Committee has asked Bayer to unblind a Phase 3 clinical trial of a Xofigo (radium-223)-based therapy for prostate cancer after data indicated more bone fractures in ... Read more

November 14, 2017November 14, 2017

ProscaVax Vaccine Stopped Prostate Cancer Progression in 80% of Patients, Phase 1 Trial Shows

News

Six injections of OncBioMune Pharmaceuticals‘ prostate cancer vaccine ProscaVax stopped the progression of the disease in 80 percent of patients in a Phase 1 clinical trial, the company announced. The results applied to ... Read more

September 14, 2017

Favorable Interim Data Presented for Tyme’s SM-88 Phase 2 Trial for Prostate Cancer Patients

News

Tyme Technologies‘ SM-88 reduced the levels of circulating cancer cells — an indicator of metastatic disease — in all prostate cancer patients treated in an ongoing Phase 2 trial, according ... Read more

June 8, 2017June 8, 2017

ESSA Pharma Presents Early Results from Clinical Trial Testing EPI-506 in End-stage Prostate Cancer

News

ESSA Pharma‘s small molecule androgen receptor inhibitor, EPI-506 (ralaniten acetate), has shown a favorable safety and tolerability profile among end-stage prostate cancer patients enrolled in a Phase 1/2 trial, as ... Read more

December 6, 2016December 6, 2016

New Imaging Agent Able to Capture Prostate Cancer Metastasis in Bone and Soft Tissue

News

A new imaging agent has been found to be safe, fast, and efficient in visualizing metastatic prostate cancer, even in regions where the visualization is often challenging, such as bone and ... Read more